5-panel drug test

Key Takeaways

The 5-panel drug test screens for THC, cocaine, amphetamines, opiates, and PCP using urinalysis to detect metabolites (byproducts of drug use).

DOT-regulated employers must use HHS-certified laboratories with chain-of-custody procedures, but non-DOT ‘look-alike’ tests are available for general workplace screening.

Detection windows vary widely: marijuana 3-30 days, cocaine 2-4 days, amphetamines 1-3 days, opiates 1-3 days, PCP 7-14 days (urine); hair tests extend to 90 days.

Practice management software like Pabau offers digital forms and secure client records that help occupational health practices document results, manage consent, maintain compliance, and store test data safely.

What is a 5-panel drug test?

The test is a legal and regulatory requirement for Department of Transportation (DOT)-regulated safety-sensitive employees in commercial driving, aviation, and maritime industries. Non-DOT employers often use “DOT look-alike” versions to maintain consistent safety standards across their workforce. Healthcare providers, occupational health practices, and wellness practitioners use digital consent forms to document participant agreement and maintain HIPAA-compliant records.

What does the 5-panel drug test screen for?

The five substance categories in a standard 5-panel test are defined by official SAMHSA (Substance Abuse and Mental Health Services Administration) guidelines and DOT regulations.

Each category includes specific drugs and metabolites:

• Marijuana (THC): Tetrahydrocannabinol, the active compound in cannabis. Detection window: 3-30 days depending on frequency of use.
• Cocaine: A stimulant drug. Detection window: 2-4 days for typical use.
• Amphetamines: Includes methamphetamine and MDMA (ecstasy), as well as prescription stimulants like dexamphetamine. Detection window: 1-3 days.
• Opiates: Includes morphine, codeine, and common opioid analgesics. Detection window: 1-3 days. (Note: Semi-synthetic opioids like oxycodone and hydrocodone require extended DOT testing as of 2018.)
• Phencyclidine (PCP): A hallucinogen and dissociative drug. Detection window: 7-14 days for typical use.

5-panel vs 10-panel drug test: Key differences

A 10-panel drug test screens for five additional substances beyond the standard 5-panel: benzodiazepines, barbiturates, methadone, propoxyphene, and quaaludes. The 5-panel is the legally mandated baseline for DOT-regulated industries, while the 10-panel is optional and typically used by employers in healthcare, construction, or high-security sectors who want more comprehensive screening.

The choice between 5-panel and 10-panel depends on the industry risk profile, employer policy, and regulatory requirements. DOT-safety-sensitive roles must use a 5-panel; non-regulated employers may select either based on their specific risk assessment. Cost is slightly higher for 10-panel testing, but the broader substance coverage provides additional insight into substance abuse patterns.

Form structure and key sections

The downloadable 5-panel drug test form template includes standardized sections required for workplace compliance and clinical accuracy. Each section serves a specific documentation purpose:

• Participant identification: Full name, date of birth, employee ID, and contact information to ensure specimen integrity and result accuracy.
• Test information: Date and time of specimen collection, testing facility name, and test type (DOT vs. non-DOT).
• Pre-test screening: Questions about current medications, supplements, and recent substance use to identify potential false-positive triggers (e.g., poppy seed consumption affecting opioid metabolites).
• Informed consent: Declaration that the participant understands the test purpose, substances screened, and result interpretation. This protects the practice legally and ensures informed participation, similar to the consent section in an advanced treatment consultation form.
• Chain of custody: A critical compliance element documenting specimen handling from collection through analysis, ensuring result validity if challenged in legal proceedings.
• Result documentation: Space for negative/positive result, specific substances detected, and Medical Review Officer (MRO) interpretation notes for positive results.
• Signature blocks: Participant signature, collector signature, and facility approval to authenticate the test and maintain audit trails.

Using digital health forms and consent documentation allows practices to standardize these sections, reduce transcription errors, and ensure every test meets regulatory requirements. Digital forms also automate compliance checks and provide instant access to secure client records for historical comparison.

How to use the 5-panel drug test form

Follow these five operational steps when administering a 5-panel drug test in your practice or occupational health setting:

1. Verify participant identity and obtain informed consent. Confirm full legal name, date of birth, and employee or participant ID. Review the test purpose (pre-employment, random workplace, post-incident, etc.) and have the participant read and sign the informed consent section. Document any questions or concerns.
2. Conduct pre-test screening and medication review. Ask about current prescription medications, over-the-counter drugs, supplements, and recent substance use. Flag any substances that could trigger false positives (e.g., poppy seeds, dextromethorphan in cough syrup, some prescription stimulants). Document findings and note any relevant medical history.
3. Collect and label the urine specimen. Use a sterile collection cup and verify the specimen meets temperature and volume requirements (typically 30-45 mL). Label the specimen with the participant’s name, date of birth, date, time, and collector initials. Maintain chain-of-custody documentation from collection onward.
4. Document chain of custody and initial specimen storage. Record the specimen’s movement through each handling step — collection, storage, transport to lab. This audit trail is essential for result validity, especially if the test is ever challenged. Use chain-of-custody forms with dated signatures at each transfer point.
5. Communicate results and provide Medical Review Officer support for positives. Negative results are typically available within 1 business day. For positive results, a Medical Review Officer (MRO) contacts the participant to confirm prescription medications or medical conditions that might explain metabolite presence. When a confirmed positive involves opioids, clinical documentation may reference ICD-10 code F11.20 if an opioid dependence diagnosis is also being made. The MRO’s interpretation is final for regulatory and legal purposes.

Digital compliance documentation tools and HIPAA-compliant patient records streamline these steps by automating form completion, maintaining audit trails, and triggering result notifications automatically.

DOT compliance and test timing

For DOT-regulated safety-sensitive employees, strict regulatory requirements apply. The test must be conducted at an HHS-certified laboratory using SAMHSA-approved collection and testing protocols. Chain-of-custody procedures are non-negotiable, and positive results require confirmed testing by GC-MS and review by a Medical Review Officer (MRO) before the employer is notified.

Negative results are typically available within 1 business day for non-DOT tests; DOT results may take 2-3 business days due to MRO review requirements. Employers should communicate result timelines to participants upfront and pair appointment confirmation and reminder workflows with efficient patient scheduling and appointment management to minimize missed collections and delays.

Who is the 5-panel drug test form helpful for?

The 5-panel drug test form template supports multiple healthcare and occupational industries:

• Occupational health practices: Providers conducting pre-employment, random, post-incident, and return-to-duty testing for employers in transportation, construction, healthcare, and manufacturing.
• HR departments and employers: Organizations managing workplace drug testing programs and needing standardized, compliant documentation.
• Substance-use treatment and rehabilitation programs: Programs monitoring compliance and sobriety through routine drug screening as part of recovery treatment plans.
• Sports medicine and athletic programs: Teams and coaches implementing drug testing as part of athlete safety protocols, often alongside a medical clearance letter confirming fitness to compete.
• Wellness clinics and integrative medicine practices: Practices providing baseline health assessments and substance-use screening for overall wellness evaluations.

Documentation and storage requirements

Benefits of using a standardized 5-panel drug test form

Compliance: Standardized forms ensure every test meets DOT regulations, SAMHSA guidelines, and HHS-certified laboratory requirements, reducing the risk of testing voids or legal challenges.

Consistency: A templated form guarantees the same information is collected for every participant, reducing missed fields and documentation errors that could invalidate results.

Efficiency: Pre-formatted sections guide collectors through required steps in the correct order, reducing testing time and participant confusion.

Audit readiness: A complete chain-of-custody trail and participant signature blocks, backed by sound records management practices, create a defensible record if test results are ever challenged in an employment or legal dispute.

Integration with practice management

Key compliance considerations

Frequently asked questions